A 21-year-old woman visited her doctor for multiple moles on her chest that first developed in her early teenage years and ...

Physicians remain skeptical that health insurers' pledges to ease prior authorization hassles will result in any meaningful action, an American Medical Association (AMA) survey found. In June 2025, a ...

An Alabama nurse was shot and killed during an attempted robbery in the hospital parking lot. The suspect had been dropped ...

Among U.S. adults with diabetes and steatotic liver disease in the All of Us cohort, new use of a GLP-1 receptor agonist was linked with a 38% to 42% lower risk of hepatic events over nearly 3 years ...

Osteoporosis was linked to a 47% increased risk of all-cause death in postmenopausal women, according to national data.

Two new physician social media communities have come online in recent weeks -- Roon, and one run by the social media personality Dr. Glaucomflecken-- joining a crowded field that includes Doximity, ...

The findings add to a growing body of evidence that treatment de-escalation is feasible and safe for favorable-risk early ...

An oncologist traveling on the cruise ship at the center of a hantavirus outbreak has been cleared to leave a special biocontainment unit in Nebraska, where he was the lone American placed in ...

No antivirals are approved as postexposure prophylaxis for household contacts of people with COVID-19. In this randomized ...

A month after stopping the GLP-1 drug because of gastrointestinal symptoms, the CLH had markedly improved, including 20/20 ...

Only about 10% to 15% of patients with this type of brain cancer survive up to 2 years. An adjuvant personalized DNA vaccine ...

The FDA granted accelerated approval to sonrotoclax (Beqalzi) as the first BCL2 inhibitor for relapsed or refractory mantle ...